Change in atherogenic lipids during prostate cancer treatment with Gonadotropin Releasing Hormones agonists (GnRH) in men with type 2 diabetes mellitus: A nationwide, population-based cohort study

Lin E., Garmo H., Hagström E.,Van Hemelrijck M., Adolfsson J., Stattin P.,Zethelius B.,Crawley D.

EUROPEAN UROLOGY（2022）

Cited 0|Views2

No score

Key words

gonadotropin releasing hormones agonists,atherogenic lipids,prostate cancer treatment,prostate cancer,diabetes,population-based

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined